Guangzhou LBP Medicine Science & Technology (688393.SH) intends to collectively reduce its shareholding by up to 1%.
Anbida (688393.SH) announced that the company recently received notifications from shareholders Zhuji Gaotejia, Chongqing Gaotejia, Hangzhou...
Guangzhou LBP Medicine Science & Technology (688393.SH) announced that the company recently received a notice of share reduction plan from its shareholders Zhuji Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong. The above-mentioned parties plan to reduce their holdings of the company's shares through the centralized bidding method, not exceeding 935,700 shares (including this number), which is equivalent to 1% of the company's current total share capital. The reduction period will be within 3 months after 15 trading days from the date of this announcement.
Related Articles

US Stock Market Move | Amgen (AMGN.US) rose 6% in trading as third-quarter sales exceeded expectations and the full-year performance guidance was raised.

US Stock Market Move | Concept stocks of encrypted currencies are rising, with Bitcoin back above $103,000.

US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations
US Stock Market Move | Amgen (AMGN.US) rose 6% in trading as third-quarter sales exceeded expectations and the full-year performance guidance was raised.

US Stock Market Move | Concept stocks of encrypted currencies are rising, with Bitcoin back above $103,000.

US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations

RECOMMEND

Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025

Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025

Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025


